We could not find any results for:
Make sure your spelling is correct or try broadening your search.
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
AbCellera (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern...
AbCellera (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m...
AbCellera (Nasdaq: ABCL) today announced financial results for the first quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated...
AbCellera (Nasdaq: ABCL), Viking Global Investors (βVikingβ), and ArrowMark Partners (βArrowMarkβ) announced today that they have entered into a collaboration to advance new antibody drug...
Period β | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.01 | -0.338983050847 | 2.95 | 3.0201 | 2.71 | 2545298 | 2.81120328 | CS |
4 | -1.1 | -27.2277227723 | 4.04 | 4.2 | 2.71 | 1984886 | 3.19445774 | CS |
12 | -1.42 | -32.5688073394 | 4.36 | 4.7499 | 2.71 | 1530253 | 3.63844003 | CS |
26 | -2.85 | -49.2227979275 | 5.79 | 6.055 | 2.71 | 1471824 | 4.39138989 | CS |
52 | -3.44 | -53.9184952978 | 6.38 | 8.05 | 2.71 | 1620331 | 5.00956439 | CS |
156 | -17.6 | -85.6864654333 | 20.54 | 22.64 | 2.71 | 1986906 | 9.58410188 | CS |
260 | -58.06 | -95.1803278689 | 61 | 71.91 | 2.71 | 1878627 | 12.07400074 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions